Daily News
Discover the Most Influential Figures in Health on TIME’s Inaugural TIME100 Health List
“TIME100 Health: Celebrating the game-changers revolutionizing healthcare and shaping a healthier world for all.”
Last Updated on May 11, 2024 by Daily News Staff
In a world where health has become an increasingly important issue, TIME magazine has taken a step towards recognizing the individuals who are leading the way in creating positive change. Today, they reveal their inaugural TIME100 Health list, a compilation of the 100 most influential people in the field of health.
To create this list, TIME reporters and editors worked tirelessly, consulting experts and sources from around the world. The result is a community of leaders from various industries, including scientists, doctors, advocates, educators, and policy-makers, who are dedicated to making a tangible difference in the world of health.
TIME Editor-in-Chief Sam Jacobs writes in his letter to readers, “Their work is enough to inspire the belief that the world of health is in the middle of a golden age of accomplishment and transformation.” This list serves as a reminder that amidst all the chaos, there are people out there using their resourcefulness and ingenuity to improve the lives of others.
The 2024 TIME100 Health list features CEOs, founders, and co-founders who are at the forefront of health innovation. Lars Fruergaard Jørgensen of Novo Nordisk, Albert Bourla of Pfizer, and Dave Ricks of Eli Lilly are just a few of the notable names on the list. These individuals have made significant contributions to the field, revolutionizing healthcare and pushing boundaries.
Women also play a prominent role on the list, with names like Sumbul Desai, Vice President of Health at Apple, and Raluca Cohen, Chief Science Officer at Salignostics, being recognized for their exceptional work. The list aims to highlight the achievements of women who have made a lasting impact in the field of health.
One of the most remarkable aspects of the TIME100 Health list is the age range of the individuals recognized. From 28-year-old Dale Whelehan, CEO of Four Day Week Global, to 99-year-old Jimmy Carter, the 39th U.S. President, who has been fighting to eradicate Guinea worm for decades, these individuals prove that age is not a barrier to making a difference.
The list also includes creatives and entertainers, showcasing the diverse range of people who are involved in shaping the future of health. Actors Michael J. Fox, Halle Berry, and Olivia Munn, authors Alua Arthur and Peter Attia, and professor and author Jonathan Haidt are just a few of the notable names on the list.
Scientists, doctors, and researchers who are at the forefront of health innovation are also recognized for their groundbreaking work. Cancer researcher Thomas Powles, research scientist Jenna Forsyth, and neurosurgeon Jocelyne Bloch are just a few of the exceptional individuals who have made significant contributions to their respective fields.
Policy-makers and government officials are also acknowledged for their role in shaping health policies. President of France Emmanuel Macron, CDC Director Mandy Cohen, and U.S. Surgeon General Vivek Murthy are just a few of the influential figures who have made a significant impact in the field of health.
To celebrate the individuals on the TIME100 Health list, TIME will be hosting the TIME100 Impact Dinner: Leaders Shaping the Future of Health on May 13th in New York City. This event will bring together leaders from various sectors to discuss innovation and trends in healthcare. The event will feature notable speakers such as Halle Berry and Marlena Fejzo, who will provide valuable insights into the future of health.
The TIME100 Health list serves as a reminder of the remarkable progress being made in the world of health. It highlights the individuals who are dedicated to making a positive impact and creating a healthier world for all. Whether you are familiar with the names on this list or not, their work is undoubtedly changing lives and shaping the future of health.
About TIME
TIME is a renowned media brand that has been in existence for over a century. It has a vast global audience of more than 120 million across its magazine and digital platforms. TIME has unparalleled access to influential individuals, earning the trust of both consumers and partners worldwide. Its unmatched ability to gather people together is aimed at sharing significant stories about individuals and ideas that shape and enhance the world. In addition to its core offerings, TIME also encompasses TIME Studios, an Emmy Award-winning film and television division, as well as a thriving live events business centered around the highly regarded TIME100 and Person of the Year franchises. TIME for Kids provides reliable news tailored for children, along with valuable resources for educators and families. The branded content studio, Red Border Studios, and the website-building platform, TIME Sites, have received accolades for their quality work. Furthermore, TIME is actively engaged in sustainability and climate action through its division, TIME CO2. With the recent launch of TIME Stamped, an e-commerce and content platform, TIME continues to expand its reach and offerings.
SOURCE TIME
health and wellness
Zepbound Linked to Lower Healthcare Costs in Adults 55+ With Obesity, Real-World Study Suggests

A new real-world study of adults over age 55 with overweight or obesity found that sustained use of Zepbound (tirzepatide) for weight management was associated with lower healthcare costs over time compared with similar adults who were not treated. Eli Lilly and Company said the findings were driven in part by lower rates of hospital admissions and emergency department visits, and were published in Diabetes, Obesity and Metabolism.
What the study found
According to Lilly, researchers estimated healthcare cost differences over time (excluding the cost of Zepbound itself) using two established analytic methods. Across both approaches, monthly healthcare costs were lower, on average, among older adults who stayed on Zepbound.
Key estimates reported in the release include:
- At six months: costs were up to 15% lower (up to $181 per patient, per month).
- At 12 months: the estimated difference widened to as much as $607 per patient, per month, reflecting up to 38% lower costs than those not treated (estimates varied by model).
In the primary analysis, adults over 55 treated with Zepbound had lower rates of hospital admissions and emergency department visits across every follow-up period, along with numerically higher rates of routine outpatient and office visitsa pattern the company said was consistent with greater engagement in routine care.
Why Medicare is part of the conversation
Lilly said the cost findings may be relevant for older adults, including those in Medicares GLP-1 Bridge program. The company noted that beginning at six months, estimated healthcare savings nearly covered the programs monthly treatment cost of $195 per patient, per month, and by 12 months the estimated savings exceeded the reported monthly treatment cost.
Its important to note the release also emphasizes a limitation: claims data do not capture Zepbounds net price, and the study excluded the cost of Zepbound from total treatment costs. That means the reported differences reflect potential savings elsewhere in care that could offset treatment costs, not the full net cost impact.
Who was included in the analysis
The retrospective observational cohort study used Komodos Healthcare Map, a database of de-identified claims data from more than 330 million individuals enrolled in U.S. healthcare plans. The analysis included 15,843 adults over age 55 (mean age 64.5) with obesity or overweight plus at least one obesity-related complication who initiated Zepbound between November 2023 and September 2025. Each Zepbound user was matched 1:1 with a control participant who met the same eligibility criteria but did not initiate GLP-1 or GIP/GLP-1 receptor agonist medication.
What Zepbound is
Zepbound (tirzepatide) is a dual GIP and GLP-1 receptor agonist indicated for adults with obesity, or some adults with overweight who also have at least one weight-related medical problem, to lose weight and keep it off. Lilly also noted Zepbound is FDA-approved to treat adults with moderate-to-severe obstructive sleep apnea and obesity, and should be used alongside a reduced-calorie diet and increased physical activity.
Safety summary (high level)
The release includes an indications and safety summary with warnings. Among other risks, Lilly notes Zepbound carries a warning about thyroid tumors, including thyroid cancer, and may cause serious side effects such as severe stomach problems, dehydration leading to kidney problems, gallbladder problems, pancreatitis, serious allergic reactions, and low blood sugar (especially when used with certain diabetes medicines). Patients should talk with a healthcare provider about risks and whether the medication is appropriate for them.
Related Links
- Zepbound (official product site): https://zepbound.lilly.com/
- Lilly newsroom: https://www.lilly.com/news
- Journal page (publisher hub): https://dom-pubs.onlinelibrary.wiley.com/journal/14631326
- Medicare (official): https://www.medicare.gov/
- FDA MedWatch (side effect reporting): https://www.fda.gov/medwatch
Source
- PRNewswire / Eli Lilly and Company press release (Aug. 26, 2026): Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study
💪 Your health journey starts here! Explore the latest health news, fitness tips, wellness trends, and healthy living advice. Share your thoughts in the comments and subscribe to the STM Daily News newsletter to stay informed and inspired every day.
Economy
U.S. Consumer Confidence Slips as Americans Grow More Cautious About the Future
U.S. consumer confidence edged lower in August as Americans became more pessimistic about jobs, income and business conditions over the next six months, despite improved views of the current economy.
NEW YORK — U.S. consumer confidence edged lower in August as Americans expressed greater concern about future business conditions, jobs and household income, even as their assessment of the current economy improved.
The Conference Board reported that its Consumer Confidence Index fell 0.8 points to 89.4 in August, down from 90.2 in July.
The relatively small decline, however, masks a widening gap between how consumers view conditions today and what they expect in the months ahead.
The Present Situation Index, which measures consumers’ assessment of current business and labor market conditions, climbed 6.8 points to 121.2, reversing three consecutive months of declines.
Meanwhile, the Expectations Index, which measures the short-term outlook for income, business and employment conditions, dropped 5.8 points to 68.2.
“Consumer confidence moderated slightly in August for a second consecutive month,” Dana M. Peterson, chief economist at The Conference Board, said in the organization’s Aug. 25 release.
Jobs Look Better Today — But Consumers Worry About Tomorrow
Americans’ perceptions of the current labor market improved considerably during August. About 27% said jobs were plentiful, up from 24.4% in July, while 19.5% said jobs were hard to get, down from 21.7%.
The outlook for the next six months was considerably weaker.
Only 14.6% expected more jobs to become available, compared with 16.4% in July. At the same time, 26.1% expected fewer jobs.
Consumers were also less optimistic about their incomes. About 17.6% expected their income to increase, down from 19.5% in July, while 13.8% expected their income to decline.
Prices Remain on Consumers’ Minds
Inflation continues to influence how Americans feel about the economy. According to The Conference Board, consumers’ written responses frequently mentioned prices, oil and gasoline, food and groceries, trade, jobs, and war or conflict.
Average and median expectations for inflation over the next 12 months also increased slightly.
Interest rates remain another concern. More than six in 10 consumers — 61.3% — expected interest rates to rise over the next year, although that was slightly lower than the 62% recorded in July.
Consumers Are Still Planning to Spend
The softer outlook hasn’t eliminated Americans’ willingness to make purchases.
Auto-buying expectations remained strong on a six-month moving-average basis, while homebuying expectations declined slightly in August but remained on a longer-term upward trend after hitting decade lows in early 2024.
Restaurants, bars and takeout; utilities; and streaming, internet and mobile services ranked among consumers’ leading planned service expenses.
Consumers were less enthusiastic about discretionary activities including movies, personal-travel hotels, airfare, amusement parks, museums and historical sites.
Why It Matters
The August numbers paint a mixed picture of the American consumer.
People are seeing some improvement in the economy they are experiencing today, particularly in the labor market. But their expectations for the next six months are becoming noticeably more cautious.
That divide matters because consumer spending represents a major part of U.S. economic activity. If concerns about employment, inflation and household income begin translating into reduced spending, weakening confidence could eventually become more significant for the broader economy.
For now, the August survey suggests Americans haven’t stopped spending — but they’re increasingly keeping an eye on what may be coming next.
The preliminary August Consumer Confidence Survey was conducted online for The Conference Board by Toluna. The survey period was Aug. 3–16, 2026.
Source: The Conference Board, August 2026 Consumer Confidence Survey®, released Aug. 25, 2026.
STM Daily News Economy News Brief
Sources
- The Conference Board — U.S. Consumer Confidence, August 2026 — Primary source for the August Consumer Confidence Index, Present Situation Index and Expectations Index.
- The Conference Board — Consumer Confidence Survey & Data — Consumer confidence survey information, methodology and release schedule.
Related Economic Data
- Bureau of Economic Analysis — Consumer Spending — Official U.S. data tracking personal consumption expenditures. Consumer spending increased 0.2% in July 2026.
- BEA — Personal Income and Outlays, July 2026 — Tracks household income, disposable income, consumer spending and saving.
- Bureau of Labor Statistics — Consumer Price Index — Official inflation data. The July 2026 CPI was up 3.4% from a year earlier; August CPI is scheduled for release September 11.
- Federal Reserve — Consumer Credit — Federal Reserve data covering revolving and nonrevolving consumer credit.
Automotive
Slate Truck Moves Closer to Reality as December 2026 Deliveries Come Into View
Slate Truck deliveries could begin in December 2026. Here’s the latest on its $24,950 price, 205-mile range, preorders and Indiana production.
Last Updated on September 6, 2026 by Daily News Staff
The $24,950 electric pickup is approaching production, but early availability will be limited—and many buyers may wait well into 2027.
Slate Auto’s minimalist electric pickup is moving closer to becoming something customers can actually park in their driveways.
After months of describing its launch simply as “late 2026,” the startup has reportedly begun asking some preorder holders whether they would be interested in taking delivery as early as December. The outreach provides the clearest indication yet of when the first production Slate Trucks could reach American roads.
That does not mean every early customer will receive a truck before the end of the year. According to emails reviewed by Business Insider, customers were offered the possibility of a December 2026 delivery, while other estimated windows stretched from early 2027 through July–September 2027.
Still, the news is an important milestone for one of the most closely watched—and most unconventional—new vehicles in America.
From an under-$20,000 promise to a $24,950 truck
When Slate emerged from stealth in 2025, much of the attention centered on the possibility of an electric truck costing less than $20,000 after federal incentives. The expiration of the federal consumer EV tax credit eliminated the subsidy that made that advertised figure possible.

Slate later established an official starting price of $24,950 before destination charges, taxes and accessories. With a reported $1,450 destination fee, the effective starting point is approximately $26,400 before a buyer begins personalizing the truck.
That remains unusually inexpensive in a market where the average new vehicle approaches $50,000. It also preserves Slate’s central argument: Many buyers might prefer a simple new vehicle over a feature-packed model carrying a much larger monthly payment.
The important question is how many buyers will remain satisfied with the base vehicle once they see what $24,950 does—and does not—include.
Basic by design
The Slate Truck starts as a two-seat, two-door electric pickup with manual windows, physical climate controls and gray composite exterior panels. There is no built-in infotainment screen or conventional factory stereo. Drivers can use a smartphone, portable speaker or optional accessories instead.
These omissions are not oversights. They are fundamental to Slate’s strategy of reducing manufacturing complexity and allowing customers to pay only for the equipment they want.
Owners will be able to add exterior wraps, upgraded audio equipment, storage systems, roof racks and other accessories. A more substantial SUV kit can add an enclosed rear section and second-row seating, transforming the small pickup into a five-passenger vehicle.
Slate says its marketplace will offer more than 200 accessories, with more than 80 percent priced below $500. That flexibility is appealing, but it also creates the possibility that a $24,950 truck could quickly approach or exceed $30,000 after buyers add color, audio, additional seating and everyday conveniences.
More range without a higher base price
One of the most meaningful improvements is the truck’s estimated driving range. Early versions of the Slate concept were associated with approximately 150 miles from the standard battery. Slate now advertises roughly 205 miles of estimated range at the same $24,950 base price.
The current specification uses a 52.7-kWh battery and a single rear-mounted electric motor. Slate says the battery can charge from 20 to 80 percent in under 30 minutes under suitable fast-charging conditions.
Approximately 205 miles should make the truck more practical for commuting, local deliveries and daily errands. It remains less suited to frequent long-distance travel than many larger EVs, but the additional range substantially strengthens the value proposition.
Final range, charging performance and other specifications remain subject to change because the vehicle is still in pre-production.
Production preparations continue in Indiana
Slate plans to manufacture the truck at a former printing facility in Warsaw, Indiana. The company says three design-verification prototype vehicles were completed ahead of schedule while expansion of the plant continues.
The factory project represents an investment of nearly $400 million and is expected to create more than 2,000 jobs. Slate has designed its production system around simplicity: composite body panels eliminate the need for a conventional paint shop, while a limited number of factory configurations should reduce assembly complexity.
The company has reported more than 180,000 refundable $50 reservations. When formal preorders opened in June 2026, customers were asked to place a $300 nonrefundable deposit—reduced to an additional $250 for existing reservation holders—to secure an estimated delivery window. The money is applied to the eventual purchase price.
Slate reportedly collected more than 10,000 of those preorder deposits within the opening hours. That shows genuine interest, but refundable reservations and early deposits are not the same as completed vehicle sales. The real test will begin when customers must finalize configurations, financing and purchase agreements.
December would be a beginning, not a full rollout
If Slate places its first customer trucks on the road in December, it will have met its broad late-2026 target. However, the first deliveries are expected to be low-volume, with production increasing during the first half of 2027.
That distinction matters. A handful of December deliveries would demonstrate that Slate can build a saleable vehicle, but it would not prove that the company can manufacture tens of thousands of trucks reliably, control costs, supply replacement parts or support customers across the country.
For a new automaker, scaling production and service can be more difficult than designing an appealing prototype. Slate must show that its low-cost philosophy works not only in the showroom but also in manufacturing, quality control, repairs and long-term ownership.
Ford Fathom adds pressure to the equation
Slate may enjoy an early lead, but it will not have the affordable electric-truck category to itself for long.
Ford’s forthcoming Fathom electric pickup is expected to start around $28,350 and reach customers in fall 2027. For only a few thousand dollars more than a base Slate, the Ford is expected to provide four doors and more conventional standard equipment.
The two trucks represent very different ideas of affordability. Slate removes features and lets owners add them later. Ford appears to be pursuing a more familiar, fully equipped small-truck experience while attempting to keep the price near $30,000.
Slate’s advantage is that it could arrive first and carry a lower advertised price. Ford’s advantages include manufacturing scale, an established service network and decades of experience selling trucks.
The bottom line
The Slate Truck is no longer merely an intriguing rendering or auto-show experiment. A firm price has been announced, preorders are underway, verification vehicles have been built, factory preparations are advancing and the first customer deliveries may now be only months away.
At $24,950—or approximately $26,400 after destination—the Slate remains one of the most interesting efforts to make a new electric vehicle genuinely affordable. Its improved estimated range makes the proposition considerably stronger than it was at launch.
But the original question has not disappeared: Will buyers embrace a truly basic truck, or will the cost of turning that blank Slate into a comfortable everyday vehicle erase too much of its price advantage?
December 2026 may give us the first real answer.
Sources and further reading
- Slate Auto: How to preorder
- Slate Auto: Vehicle specifications
- Slate Auto: Warsaw factory update
- Business Insider: Earliest Slate deliveries
- Axios: Indiana-built EVs target affordability
Vehicle specifications, prices and delivery estimates remain subject to change before production.
🚗 Stay in the driver’s seat with the latest automotive news, vehicle reviews, industry updates, recalls, and buying tips. Share your opinions in the comments and subscribe to the STM Daily News newsletter for the latest Consumer Corner Automotive stories delivered straight to your inbox.
